Xponance Inc. trimmed its holdings in Maximus, Inc. (NYSE:MMS – Free Report) by 6.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,896 shares of the health services provider’s stock after selling 581 shares during the quarter. Xponance Inc.’s holdings in Maximus were worth $752,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in MMS. PNC Financial Services Group Inc. boosted its stake in Maximus by 16.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 2,520 shares of the health services provider’s stock worth $188,000 after purchasing an additional 354 shares during the period. Bank of Montreal Can boosted its stake in Maximus by 9.0% in the 1st quarter. Bank of Montreal Can now owns 15,203 shares of the health services provider’s stock worth $1,179,000 after purchasing an additional 1,255 shares during the period. Panagora Asset Management Inc. boosted its stake in Maximus by 39.9% in the 1st quarter. Panagora Asset Management Inc. now owns 4,977 shares of the health services provider’s stock worth $373,000 after purchasing an additional 1,419 shares during the period. Rhumbline Advisers boosted its stake in Maximus by 4.1% in the 1st quarter. Rhumbline Advisers now owns 242,103 shares of the health services provider’s stock worth $18,146,000 after purchasing an additional 9,510 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its stake in Maximus by 11.3% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 22,694 shares of the health services provider’s stock worth $1,701,000 after purchasing an additional 2,313 shares during the period. 99.30% of the stock is currently owned by institutional investors.
Insider Activity at Maximus
In related news, Director Michael J. Warren sold 2,490 shares of the stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $79.53, for a total transaction of $198,029.70. Following the sale, the director now owns 3,890 shares in the company, valued at approximately $309,371.70. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other Maximus news, CEO Bruce Caswell bought 3,141 shares of the firm’s stock in a transaction dated Friday, August 4th. The stock was acquired at an average cost of $79.07 per share, for a total transaction of $248,358.87. Following the completion of the transaction, the chief executive officer now owns 210,484 shares in the company, valued at $16,642,969.88. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Michael J. Warren sold 2,490 shares of Maximus stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $79.53, for a total value of $198,029.70. Following the sale, the director now owns 3,890 shares of the company’s stock, valued at $309,371.70. The disclosure for this sale can be found here. 1.30% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Read Our Latest Research Report on Maximus
Maximus Stock Performance
NYSE:MMS opened at $74.68 on Friday. The stock’s fifty day moving average is $80.09 and its 200 day moving average is $81.27. Maximus, Inc. has a fifty-two week low of $54.46 and a fifty-two week high of $89.69. The firm has a market capitalization of $4.54 billion, a PE ratio of 26.67 and a beta of 0.70. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.46 and a current ratio of 1.46.
Maximus (NYSE:MMS – Get Free Report) last released its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.78 earnings per share for the quarter, missing the consensus estimate of $1.14 by ($0.36). Maximus had a net margin of 3.56% and a return on equity of 15.11%. The company had revenue of $1.19 billion for the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter in the previous year, the company posted $0.78 EPS. The business’s quarterly revenue was up 5.6% on a year-over-year basis. On average, sell-side analysts anticipate that Maximus, Inc. will post 3.88 earnings per share for the current year.
Maximus Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, August 31st. Investors of record on Tuesday, August 15th were issued a dividend of $0.28 per share. The ex-dividend date was Monday, August 14th. This represents a $1.12 annualized dividend and a yield of 1.50%. Maximus’s payout ratio is presently 40.00%.
Maximus Profile
Maximus, Inc provides business process services (BPS) to government health and human services programs. It operates through three segments: U.S. Services, U.S. Federal Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Articles
- Five stocks we like better than Maximus
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- CarMax Slides On Earnings Disappointment, Time To Celebrate?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- The Next Stage Of Google’s Rally Just Started
- Most Volatile Stocks, What Investors Need to Know
- Can Investors Win the Race with Dividend Achiever Nike?
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
